Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria
- PMID: 21320539
- DOI: 10.1016/j.vaccine.2011.01.104
Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria
Abstract
Austria was the first country in Europe implementing a universal mass vaccination program against rotavirus gastroenteritis (RV-GE) for all infants nationwide. Epidemiological data from a hospital based surveillance system show that incidence rates of children hospitalized with RV-GE decreased in 2009 compared to 2008 and compared to the prevaccination period 2001-2005. Decreasing hospitalization-rates from RV-GE were observed in children of all age groups, even in those not eligible for vaccination according to their age, suggesting herd immunity induced by universal mass vaccination against RV-GE. In 2009 the disease burden was highest in children below three months of age stressing the importance of the early start of the immunization course.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.Pediatr Infect Dis J. 2010 Apr;29(4):319-23. doi: 10.1097/INF.0b013e3181c18434. Pediatr Infect Dis J. 2010. PMID: 19935446
-
Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee. Pediatr Infect Dis J. 2011. PMID: 21183837
-
Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.Scand J Infect Dis. 2011 Jan;43(1):58-63. doi: 10.3109/00365548.2010.508462. Epub 2010 Aug 31. Scand J Infect Dis. 2011. PMID: 20807022
-
Real-world impact of rotavirus vaccination.Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S1-5. doi: 10.1097/INF.0b013e3181fefa1f. Pediatr Infect Dis J. 2011. PMID: 21183833 Review. No abstract available.
-
Update on Rotarix: an oral human rotavirus vaccine.Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Expert Rev Vaccines. 2009. PMID: 19943758 Review.
Cited by
-
Health impact of rotavirus vaccination in China.Hum Vaccin Immunother. 2024 Dec 31;20(1):2386750. doi: 10.1080/21645515.2024.2386750. Epub 2024 Sep 13. Hum Vaccin Immunother. 2024. PMID: 39269780 Free PMC article.
-
Molecular evolutionary analysis of novel NSP4 mono-reassortant G1P[8]-E2 rotavirus strains that caused a discontinuous epidemic in Japan in 2015 and 2018.Front Microbiol. 2024 Jul 10;15:1430557. doi: 10.3389/fmicb.2024.1430557. eCollection 2024. Front Microbiol. 2024. PMID: 39050631 Free PMC article.
-
Rotavirus Vaccine Impact since Its Introduction in the National Immunization Program of Argentina.Infect Dis Ther. 2023 Feb;12(2):513-526. doi: 10.1007/s40121-022-00709-6. Epub 2022 Dec 15. Infect Dis Ther. 2023. PMID: 36520328 Free PMC article.
-
Characterization of Rotavirus Infection in Hospitalized Children under 5 with Acute Gastroenteritis 5 Years after Introducing the Rotavirus Vaccines in South Korea.Children (Basel). 2022 Oct 27;9(11):1633. doi: 10.3390/children9111633. Children (Basel). 2022. PMID: 36360361 Free PMC article.
-
Defining the Recipe for an Optimal Rotavirus Vaccine Introduction in a High-Income Country in Europe.Viruses. 2022 Feb 18;14(2):425. doi: 10.3390/v14020425. Viruses. 2022. PMID: 35216018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical